|
GantrisinDrug - Gantrisin The trade name of the product as shown on the labeling.
Dosage -
INJECTABLE; INJECTION
Active Ingredient(s) -
Sulfisoxazole Diolamine
Strength -
EQ 400MG BASE/ML
Applicant -
ROCHE
New Drug Application (NDA) Number -
006917
Product Number -
001
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Hoffmann La Roche Inc
Gantrisin
Sulfisoxazole 500mg Tablet; Oral
Sulfisoxazole 500mg Tablet; Oral Sulfisoxazole 500mg Tablet; Oral Sulfisoxazole 500mg Tablet; Oral Sulsoxin 500mg Tablet; Oral Lipo Gantrisin Eq 1gm Base/5ml Emulsion; Oral Gantrisin Pediatric Eq 500mg Base/5ml Suspension; Oral Gantrisin Eq 500mg Base/5ml Syrup; Oral Gantrisin Eq 400mg Base/ml Injectable; Injection Sulfisoxazole 500mg Tablet; Oral NewDrugInformation |